All News
Filter News
Found 1,128 articles
-
Evotec AG Acquires Zebrafish Screening Operations of Summit Corporation
5/7/2009
-
Evotec AG to Re-Engineer Drug Discovery and Development Operations, Lays Off 45; U.S. Operations Will be Wound Down With Immediate Effect
5/6/2009
-
Evotec AG to Report First Quarter 2009 Results On May 12, 2009
5/6/2009
-
Top Executives From Biotrial, A Leading Contract Research Organization (CRO) In The Field Of Early Compound Development, To Speak At 3rd AGAH/Club Phase I Joint Annual Meeting, A Key European Clinical Pharmacology Event
4/22/2009
-
Evotec AG Reports Results of Phase II Proof-of-Concept Study With EVT 302
4/14/2009
-
KeyNeurotek Pharmaceuticals Completes € 8.2 Million ($ 10.8 Million) Series C Financing Round
4/7/2009
-
Evotec AG Restructures and Implements "Evotec 2012 - Action Plan to Focus and Grow"; Reduces Headcount By 50
3/27/2009
-
Evotec AG Announces Financial Results for 2008
3/27/2009
-
Evotec AG: Fiscal Year 2008 Results Presentation on March 27, 2009 Live on the Internet
3/25/2009
-
Peter J. Solomon Launches Pharma Practice
3/19/2009
-
Evotec AG and Roche to Develop EVT 101 for Treatment-Resistant Depression; Deal Valued at More Than $300 Million
3/9/2009
-
Evotec AG Appoints Dr. Werner Lanthaler as Chief Executive Officer
3/6/2009
-
KeyNeurotek Pharmaceuticals Concludes Patient Recruitment In A Phase IIa Traumatic Brain Injury Study With KN38-7271 On Schedule
12/15/2008
-
Joern Aldag Resigns as CEO of Evotec AG
12/11/2008
-
Evotec AG Announces Three-Year Drug Discovery Collaboration with Novartis Corporation (JOBS); Deal Could Exceed $28 Million
12/3/2008
-
Evotec AG to Present At the 20th Annual Piper Jaffray Health Care Conference in New York
12/1/2008
-
Evotec AG Reports Strong Third Quarter 2008 and Improves Full-Year Guidance
11/14/2008
-
Evotec AG to Report Third Quarter 2008 Results On November 14, 2008
11/7/2008
-
Evotec AG Earns Two Milestone Payments From Boehringer Ingelheim Corporation
10/30/2008
-
Evotec AG Reports Phase I Safety Data From Tyramine Interaction Study With EVT 302
10/27/2008